ANEST
LIVE

Serial Number

79355844

Owner

5MED GmbH

Attorney

Katrin Lewertoff

Filing Date

Apr 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ANEST Trademark

Serial Number: 79355844 • Registration: 7273115

ANEST is a trademark filed by 5MED GmbH on April 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

5MED GmbH (2 trademarks)

Lena-Christ-Strasse 2

Entity Type: 99

Welding GmbH & Co. KG (2 trademarks)

Esplanade 39

Entity Type: 99

Helm AG (17 trademarks)

Nordkanalstr. 28

Entity Type: 28

Trademark Details

Filing Date

April 7, 2022

Registration Date

January 16, 2024

Published for Opposition

October 31, 2023

Goods & Services

Medical apparatus and instruments for use in anesthesiology and intensive care medicine; Veterinary apparatus and instruments for use in anesthesiology and intensive care medicine; Dental apparatus and instruments for use in anesthesiology and intensive care medicine; Medical devices, namely, devices for transporting medications into the patient, namely, applicators in the nature of disposable syringes for medical use, anesthetic inhalers sold empty, implantable ports, drug delivery patches sold without medicine for use in anesthesiology and intensive care medicine; Medical instruments for use in anesthesiology and intensive care medicine

Pharmaceutical preparations for use in anesthesiology and intensive care medicine, namely, analgesics, antibiotics and anesthetics for surgical and non-surgical use; Medicinal healthcare preparations to reduce strong pain after surgeries and in emergencies, or to prevent bacterial infections, for use in anesthesiology and intensive care medicine; Medicinal preparations and substances to reduce strong pain after surgeries and in emergencies, or to prevent bacterial infections, for use in anesthesiology and intensive care medicine; Medicine to reduce strong pain after surgeries and in emergencies, or to prevent bacterial infections, for use in anesthesiology and intensive care medicine; Medicines for human purposes to reduce strong pain after surgeries and in emergencies, or to prevent bacterial infections, for use in anesthesiology and intensive care medicine

Research and development of new products for others; Technical writing for others; Technical project studies, namely, technical research in the field of pharmaceutical studies; Medical research services; Conversion of physical data and documents into electronic media format; Technical research in the field of pharmaceutical studies; Hosting of databases, namely, hosting of on-line databases of others; Providing search engines for the internet; Quality control for others; Chemical analysis; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others

Medical clinic services; Provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Hospitals, namely, hospital services; Pharmacy advice, namely, pharmaceutical advice; Pharmaceutical consultation; Medical consultation; Medical assistance; Medical services; Advice in relation to medical services and health care provided at medical clinics for business and health staff; Health care

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2024 FINO
LIMITATION OF GOODS RECEIVED FROM IB
May 11, 2024 LIMG
GENERIC MADRID TRANSACTION SENT TO IB
Apr 17, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 17, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 16, 2024 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 16, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Oct 31, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 11, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 11, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 20, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 24, 2022 REPR